Roseola laboratory findings

Jump to navigation Jump to search

Roseola Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Roseola from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Roseola laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Roseola laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Roseola laboratory findings

CDC on Roseola laboratory findings

Roseola laboratory findings in the news

Blogs on Roseola laboratory findings

Directions to Hospitals Treating Type chapter name here

Risk calculators and risk factors for Roseola laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

Laboratory findings

  • The diagnosis of HHV-6A, HHV-6B, and HHV-7 infections is based on gene amplification (PCR). It allows for the detection and quantification of the viral genome, than on serology, which is mainly indicated in case of primary infection.

References